Real-World Primary Resistance to First-Line Immune-Based Combinations in Patients with Advanced Renal Cell Carcinoma (ARON-1).
Saved in:
| Title: | Real-World Primary Resistance to First-Line Immune-Based Combinations in Patients with Advanced Renal Cell Carcinoma (ARON-1). |
|---|---|
| Authors: | Santini D; Department of Radiological, Oncological and Pathological Sciences, Policlinico Umberto I, University of Rome, Rome, Italy., Li H; Department of Internal Medicine, Division of Medical Oncology, University of Kansas Cancer Center, Westwood, KS, USA., Roviello G; Department of Health Sciences, Section of Clinical Pharmacology and Oncology, University of Florence, Florence, Italy., Park SH; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Grande E; Department of Medical Oncology, MD Anderson Cancer Center Madrid, Madrid, Spain., Kucharz J; Department of Uro-Oncology, Maria Sklodowska-Curie National Research Institute of Oncology Warsaw, Warsaw, Poland., Basso U; Medical Oncology 1 Unit, Department of Oncology, Istituto Oncologico Veneto IOV IRCCS, Padova, Italy., Fiala O; Department of Oncology and Radiotherapeutics, Faculty of Medicine, University Hospital in Pilsen, Charles University, Pilsen, Czech Republic.; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic., Monteiro FSM; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil.; Hospital Sírio-Libanês, Brasília, DF, Brazil., Poprach A; Masaryk Memorial Cancer Institute, Brno, Czech Republic.; Faculty of Medicine, Masaryk University, Brno, Czech Republic., Buti S; Department of Medicine and Surgery, University of Parma - Oncology Unit, University Hospital of Parma, Parma, Italy., Molina-Cerrillo J; Department of Medical Oncology, Hospital Ramón y Cajal, Madrid, Spain., Catalano M; Department of Health Sciences, Section of Clinical Pharmacology and Oncology, University of Florence, Florence, Italy., Buchler T; Department of Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic., Seront E; Department of Medical Oncology, Cliniques Universitaires Saint-Luc, Brussels, Belgium., Ansari J; Medical Oncology, Tawam Hospital, Al Ain, United Arab Emirates., Myint ZW; Markey Cancer Center, University of Kentucky, Lexington, KY, USA., Ghosn M; Hematology-Oncology Department, Faculty of Medicine, Saint Joseph University of Beirut, Beirut, Lebanon., Calabrò F; Medical Oncology, IRCCS, National Cancer Institute Regina Elena, Rome, Italy., Kopp RM; Clinical Oncology, Sociedad de Oncología y Hematología del Cesar, Valledupar, Colombia., Bhuva D; Department of Medical Oncology, Army Hospital Research and Referral, New Delhi, India., Bourlon MT; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico., Roberto M; Department of Hematology, Oncology and Dermatology, UOC Oncologia A, Policlinico Umberto I University Hospital, Sapienza University of Rome, Rome, Italy., Di Civita MA; Department of Hematology, Oncology and Dermatology, UOC Oncologia A, Policlinico Umberto I University Hospital, Sapienza University of Rome, Rome, Italy.; Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy., Mollica V; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Marchetti A; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.; Department of Medical and Surgical Science (DIMEC), University of Bologna, Bologna, Italy., Soares A; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil.; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil., Battelli N; Oncology Unit, Macerata Hospital, Macerata, Italy., Ricci M; General Director AST3, Macerata, Italy., Kanesvaran R; National Cancer Centre Singapore, Singapore, Singapore., Bamias A; 2nd Propaedeutic Department of Internal Medicine, School of Medicine, ATTIKON University Hospital, National and Kapodistrian University of Athens, Athens, Greece., Porta C; Interdisciplinary Department of Medicine, Division of Medical Oncology, University of Bari 'Aldo Moro', AOU Consorziale Policlinico di Bari, Bari, Italy., Massari F; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy. fmassari79@gmail.com.; Department of Medical and Surgical Science (DIMEC), University of Bologna, Bologna, Italy. fmassari79@gmail.com., Santoni M; Oncology Unit, Macerata Hospital, Macerata, Italy. |
| Source: | Targeted oncology [Target Oncol] 2024 Nov; Vol. 19 (6), pp. 893-903. Date of Electronic Publication: 2024 Sep 17. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: Springer-Verlag France Country of Publication: France NLM ID: 101270595 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1776-260X (Electronic) Linking ISSN: 17762596 NLM ISO Abbreviation: Target Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
